FEATURED POST

The Blissful Ignorance of American neo-Nazis

Image
The violent white supremacist rally in Charlottesville reflects the dangerous, open-the-floodgates culture that having a Bully-in-Chief in the White House has created in America.
Hundreds of protesters descended upon Charlottesville, Virginia, on August 12, 2017 for a “Unite the Right” rally. 
The rally was dispersed by police minutes after its scheduled start at noon, after clashes between rallygoers and counter-protesters, and after a torchlit pre-rally march Friday night descended into violence.
But later that day, as rallygoers began a march and counterprotests continued, a reported Nazi sympathizer drove a car into a crowd of counterprotesters, killing one and injuring 19.
Self-described “pro-white” activist Jason Kessler organized the rally to protest the planned removal of a statue of confederate general Robert E. Lee from a park in Charlottesville. 
Kessler is affiliated with the alt-right movement that uses internet trolling tactics to argue against diversity and “identity po…

Drug company's withdrawal limits death penalty options in Alabama

Drug giant Pfizer's decision to ban the use of its products in executions won't necessarily stop capital punishment in Alabama, one expert says, but it's clear the state's lethal injection options are running out.

"The sources of drugs on the open market are gone," said Robert Dunham, director of the Death Penalty Information Center, a group that studies the death penalty. "States are going to have to go underground, as it were, to obtain the drugs for executions."

Pfizer, the New-York based pharmaceutical company, announced Friday that it "strongly objects to the use of its products as lethal injections for capital punishment" statement on the company's website.

One of the world's largest drug producers, Pfizer joins several other major drug producers in a boycott that has been slowing the pace of executions in America for years. European-owned companies have backed out due to widespread opposition to the death penalty in their home countries. In America, major medical and pharmacists' associations have declared their opposition to participation in executions, arguing that the medical arts shouldn't be used to kill.

Death penalty critics hailed Pfizer's decision last week as a major step toward cutting off all execution drugs. Pfizer spokeswoman Rachel Hooper said Monday that the company simply clarified an existing policy, 1 the company has held since it acquired Hospira, 1 of the first major American drug producers to halt sales of drugs for lethal injection.

"It's not a new policy so much as an update of a Hospira policy," Hooper said.

Hooper declined to answer questions about whether the company had sold drugs to Alabama's prison system.

Alabama has executed only 2 inmates in the past 4 years, compared to 17 in the 4 years before that.

The drug boycott was a major factor in that lull. Federal regulators seized the state's execution drugs, acquired through back channels, in 2011. Alabama switched to a new main execution drug, but its supply of that drug expired in 2014 while lawyers debated the legality of the switch.

In January, the state executed convicted murderer Christopher Brooks with injections of midazolam, rocuronium and sodium chloride. State officials have never acknowledged where they bought the drugs. One maker of midazolam, the Illinois-based company Akorn, joined the boycott after Alabama officials mentioned the company in court filings in a death penalty case.

Dunham said the Pfizer decision does close off access to mass-produced versions of the drugs typically used in executions. He said states could still turn to compounding pharmacies - specialty pharmacies that make small, customized batches of drugs - though many compounding pharmacists would likely refuse if state officials can't produce a prescription for the drugs.

Alabama seems to have had trouble with that approach. In court records filed in December, state officials said they asked every compounding pharmacist in the state to make pentobarbital - once the state's primary execution drug - and every pharmacist turned them down.

Attempts to reach Department of Corrections officials Monday for comment on the Pfizer decision were unsuccessful.

It's not clear just how much midazolam the state has on hand for future executions, where those drugs come from, or how long they'll last.

Court documents filed earlier this month again included instructions for the use of midazolam made by Akorn, which has asked that its drugs not be used for lethal injection. The court filings include photocopies of labels from boxes of midazolam.

The expiration dates on those labels weren't visible.

Source: Anniston Star, May 17, 2016

- Report an error, an omission: deathpenaltynews@gmail.com - Follow us on Facebook and Twitter

Most Viewed (Last 7 Days)

Indonesia: The journey from death row

On death row, a whisper saved his life. He still does not know why

Iran: Shameful execution of Alireza Tajiki, arrested at age 15

Florida Supreme Court strikes blow to death row inmates

ISIS releases new pictures of gay man being thrown off a roof in Syria

Bali nine Renae Lawrence, other Australians recommended for sentence cut

Iran: Call to Save 7 Prisoners on the Verge of Execution

Maldivian and international human rights groups urge Maldives President to halt execution plans

Iran: Execution Sentence Issued for Two Afghan Juvenile Offenders

Iran: Four Prisoners Hanged, Authorities Silent